Acceder

Farmas USA

136K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
11.966 / 17.032
#95722

Re: Farmas USA

FED: yo daba por hecho que los subían en Diciembre. Estuve recientemente en una reunión con varios analistas que así lo creen...ojalá lo retrasen.

#95723

Re: Farmas USA

TGTX
Si el tema es sobre el "enrollment" me parece extraño que se dijera hace poco que el enrollment iba más rápido de lo esperado.

#95724

Re: Farmas USA

viendo ese gráfico de IBB estaríamos comenzando la 5 de ondas de Elliot

#95727

Re: Farmas USA

Horizon Pharma plc Named One of the Country's Best Medium Workplaces by Fortune Magazine

 

DUBLIN, Ireland, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it has been selected to Fortune's  "Best Small and Medium Workplaces" list.  Horizon ranked #22 on the Best Medium Workplaces List.

"It is an honor to be recognized by Fortune as one of the 2016 Best Medium Workplaces," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc.  "At Horizon, our mission is to improve the lives of patients with conditions such as rheumatoid arthritis, gout and very rare diseases.  We are successful because of our diverse, creative and collaborative employees who are driven by a passion to improve the lives of those living with these challenging and often debilitating conditions."

Horizon won this accolade based on employees' anonymous responses to an extensive survey about their levels of trust, pride and camaraderie at work.   Great Place to Work® reviewed the survey results of more than 52,000 employees from hundreds of companies in the ranking process.

Te puede interesar...
  1. Primeras dudas sobre la 'Trumponomics', ¿corrección o toma de beneficios?
  2. Nvidia bate expectativas pero decepciona. Insiders reafirman su posición
  1. Inflación y tipos en el punto de mira, la historia no se repite pero rima
  2. La Euforia Post-Trump: ¿Calma o Tormenta en el Mercado?